Finally, one place to get all the court documents we need. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Atef Eltoukhy was born in Sharkia, Egypt on February 3, 1951. The dynamic duo of Helmy and AmirAli believes that the key to conquering cancer is to expand efforts to detect the cancers most likely to be cured through early intervention and access to their molecular information throughout all stages of the disease. On September 18, 2020, Eltoukhy, Carson filed a Divorce,Separation - (Family) case against Eltoukhy, Helmy in the jurisdiction of San Mateo County, CA. In addition, Meghan Joyce, COO, and EVP of Platform at Oscar Health will join the Board as an Independent Director. ; Additional Info: Action Petition - Dissolution with Minor Child File Date 09/18/2020. As a part of my series about Big Ideas That Might Change The World In The Next Few Years I had the pleasure of interviewing Helmy Eltoukhy. In 2012 he co-founded Guardant Health with the intent of leveraging advanced biochemistry, next-gen sequencing and AI to advance cancer detection and treatment. Superior Courts See the full leadership team at Craft. (Id. Its a simple blood draw that is minimally invasive, especially when compared to other existing screening modalities, and can provide potentially life-changing genomic information that was not available to the oncologist prior to the testing. Our recent success in bringing to market Guardant360 CDx, the first FDA-approved comprehensive liquid biopsy for all solid cancers, and a test that is covered by many private payers and Medicare for all advanced tumors, has provided us with many important learnings as we continue to look ahead to bringing future products to market for more patients earlier in the cancer care continuum. Executive Summary. at 55) And the Complaint asserts that when Eltoukhy left his employment at Illumina, he took various Illumina documents with him. Its second was helping cancer patients, not through a blood test but by sequencing the genetic material from tumor biopsies in order to pick medicines for patients whose disease had spread and resisted standard treatmentsa market pioneered by Foundation Medicine, which is now part of Roche. Intellectual humility is a good thing. Helmy Eltoukhy in 2013 left the genetic sequencing giant Illumina to cofound Guardant Health. I think with innovation, its vitally important to have confidence, that audaciousness, that optimism and can-do spirit, but I think a challenge arises when this is not combined with intellectual humility particularly when it comes to science and healthcare. He joined the Stanford Genome Technology Center as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a postdoctoral fellow in 2006 to work on low-cost DNA sequencing technologies. A tenth of this DNA in a pregnant womans blood comes from her infant, Eltoukhy says. ; Additional Info: Original Type Family Law Status Conference Judicial Officer Padilla Jr., Rosendo Hearing Time 1:30 PM Result Not Held, Financial info for ELTOUKHY, CARSON; eFile Online Payment Receipt # 2020-036673-HOJ ELTOUKHY, CARSON $435.00, Financial info for ELTOUKHY, CARSON; Transaction Assessment $435.00, Financial; ELTOUKHY, CARSON; Total Financial Assessment $515.00; Total Payments and Credits $515.00, Cause Of Action. Its my pleasure, thanks for having me. Divorce,Separation - Prior to founding our company, Dr. Eltoukhy held various positions at Illumina, Inc. from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. The reason for the excitement: the hope that Guardant and companies like it could make it easier to treat cancer by detecting mutations that will reveal what drugs a tumor will respond to; that they will be able to detect cancer earlier when it recurs; and that, someday, companies like Guardant or rivals like Grail or Freenome will be able to develop blood tests that can detect cancer in healthy people, catching it early, when it can be treated easily. What are your 5 Things I Wish Someone Told Me Before I Started and why. [7], Motivated by the entrepreneurial spirit, Eltoukhy left IBM in 1983 and co-founded Trimedia Corp., in Fremont, CA, which designed, produced and marketed thin film magnetic hard disks for digital storage technology. Guardant Health's current Chief Executive Officer is Helmy Eltoukhy. Diffusion Enhancement Due to LowEnergy Ion Bombardment During Sputter Etching and Deposition. Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. Our reports have gotten simpler and simpler over the years by narrowing their scope to what truly matters for patient care. We try to imagine all patients as our own family members. DocketCourt Trial - Short Cause. Helmy is passionate about healthcare and impact, and serves on the Cancer Leadership Council of UCSF Cancer Center. . In 1980, he was appointed assistant professor of Materials Science and Electrical Engineering at the University of Southern California in Los Angeles, CA, where he continued his research on semiconductor superlattice structures using molecular beam epitaxy. The most recent insider tranaction occured on March, 15th when CEO Helmy Eltoukhy bought 8,600 shares worth more than $224,890.00. The corporate mailing address for Dr. Eltoukhy and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Talasaz went to Stanford in 2001, earned a Ph.D. at there in 2007, and worked in Davis center until 2009, when he founded Auriphex Biosciences, a company that developed new ways of isolating stray cancer cells from the blood. Teen TikToker Says Fart Led To Uterus Coming Out Her Vagina. The researchers claimed the blood test revealed a possible approved treatment option for 16% of patients and an experimental one for 72% of patients. AIR INTERNATIONAL (US) INC. vs BYTON NORTH AMERICA CORPORATION, Bradley Garlinghouse vs. Kristen Mautner Garlinghouse. Why is this public record being published online? Interlayer Diffusion in InSb/GaSb Superlattice Structure Grown by Multitarget RF Sputtering, Surface Properties of Magnetic Rigid Disks for HighDensity Data Storage. Can you tell us that story? A Bay Area native and the son of an entrepreneur, Helmy says his dad gave him the advice that eventually led to him co-founding Guardant: "When you start something new, focus on impact first. AmirAli Talasaz, President of Guardant Health, addresses employees. Powered and implemented by Interactive Data Managed Solutions. Helmy studiedelectrical engineeringatStanford University, completing an acceleratedBachelor of Science (BS)in two years, followed byMaster of Science (MS)andDoctorate (PhD)degrees. (Please share a story or example for each.). Significant News Only. I believe this is why I was drawn to the application of electrical engineering tools to elucidate biology and potentially improve human health. Likewise, the Eltoukhy Family Foundation funded endowed fellowships for the benefit of Egyptian/Middle Eastern students at the International House at UC Berkeley.[32]. Learn More on Guardant Health's active insiders. You have the added complexities of proving the clinical utility of your test to improve healthcare outcomes. sputter induced micro-texturing enhancement for magnetic head structures. The corporate mailing address for Dr. Eltoukhy and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. ; Additional Info: Judicial Officer Cho Sharon K. Hearing Time 9:00 AM Cancel Reason Vacated Comment 2/27/23-3/10/23 5 DAY ESTIMATE, Financial info for ELTOUKHY, HELMY; eFile Online Payment Receipt # 2023-005493-HOJ ELTOUKHY, HELMY $20.00, Financial info for ELTOUKHY, HELMY; Transaction Assessment $20.00, Stipulation. Under Eltoukhys direction as CEO, Guardant Health raised over one billion dollars in financing, launched three products, established collaborations with oncology researchers, and gained recognition as a healthcare innovator inliquid biopsyapproaches used for cancer diagnosis and research. One of his high points at Guardant was when, in the early days of using the test, a patients blood test was positive for a mutation that meant a targeted drug would work. We will email you when the process is complete. I cover science and medicine, and believe this is biology's century. I knew fairly early in my career that I wanted to dedicate my lifes work to pursuits that held high positive social impact. Mr. Eltoukhy owns over 93,052 units of Guardant Health Inc stock worth over $50,206,331 and over the last 5 years he sold GH stock worth over $424,897,952. She was administered the therapy and had a fantastic response with her disease going into remission. Guardant Health was founded to pioneer non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine treatment, and research. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. 2020-02-26. Post a comment / Mar 21, 2022 at 1:43 PM. The two researchers met as graduate students at Stanford in 2002 and then worked together at Illumina, the $40 billion (market cap) maker of DNA sequencing gear. There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. Guardants first product, Guardant360, looked at mutations in 54 genes. Eltoukhy, Carson, You can see the complete history of Mr. Eltoukhy stock trades at the bottom of the page. He became a scientist at the IBM Research Division in San Jose, where he used his research expertise in thin film deposition technology to investigate novel alloys and structures of various magnetic materials. FinancialFinancial info for ELTOUKHY, HELMY; eFile Online Payment Receipt # 2023-005493-HOJ ELTOUKHY, HELMY $20.00, FinancialFinancial info for ELTOUKHY, HELMY; Transaction Assessment $20.00, DocketStipulation. Guardant raised $360 million in May, and aims to sequence more than 1 million cancer patients' DNA within five years. I had lost my dearest friends and family to cancer, Talasaz says. Early adopters are different than the bulk of eventual users and they care about different aspects of the product, even in healthcare. Learn More on Helmy Eltoukhy's contact information. There are 2 executives at Guardant Health Inc getting paid more, with MichaelWiley having the highest compensation of $2,216,070.

Diy Google Home Hub, Articles H